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Small RNA zippers lock miRNA molecules and
block miRNA function in mammalian cells
Lingyu Meng1,2,*, Cuicui Liu1,2,*, Jinhui Lü1,3,*, Qian Zhao1, Shengqiong Deng1, Guangxue Wang1, Jing Qiao1,
Chuyi Zhang1, Lixiao Zhen1, Ying Lu1, Wenshu Li3, Yuzhen Zhang1, Richard G. Pestell4, Huiming Fan1,
Yi-Han Chen1, Zhongmin Liu1 & Zuoren Yu1

MicroRNAs (miRNAs) loss-of-function phenotypes are mainly induced by chemically
modiﬁed antisense oligonucleotides. Here we develop an alternative inhibitor for miRNAs,
termed ‘small RNA zipper’. It is designed to connect miRNA molecules end to end, forming a
DNA–RNA duplex through a complementary interaction with high afﬁnity, high speciﬁcity and
high stability. Two miRNAs, miR-221 and miR-17, are tested in human breast cancer cell lines,
demonstrating the 70B90% knockdown of miRNA levels by 30–50 nM small RNA zippers.
The miR-221 zipper shows capability in rescuing the expression of target genes of miR-221
and reversing the oncogenic function of miR-221 in breast cancer cells. In addition, we
demonstrate that the miR-221 zipper attenuates doxorubicin resistance with higher efﬁciency
than anti-miR-221 in human breast cancer cells. Taken together, small RNA zippers are a
miRNA inhibitor, which can be used to induce miRNA loss-of-function phenotypes and
validate miRNA target genes.
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icroRNAs (miRNAs) are a class of singled-stranded
small RNA molecules that regulate the stability or
translational efﬁciency of targeted messenger RNAs1.
miRNAs are initially transcribed to primary miRNA, which are
then cleaved by endonucleases to generate hairpin-structured
precursor miRNAs (pre-miRNAs) with 60B70 nucleotides
in length. After transporting to the cytoplasm by Exportin-5,
pre-miRNAs are processed by Dicer to generate mature miRNAs
with 18B24 nt in length2,3. More than 2,000 miRNA sequences
have been identiﬁed or predicted from human origin tissues or
cells4. miRNAs are mediated by RNA-induced silencing complex
that lead to base-pairing interactions between an miRNA and
the binding site of its target mRNAs mostly within the
30 -untranslated region (30 -UTR). miRNAs regulate diverse
biological processes including cell fate determination, cell cycle
progression, stem cell self-renewal, cancer initiation, progression
and metastasis5–11.
Small non-coding RNA-based diagnostic and therapeutic
applications for human cancer are expected in the near future.
Synthetic miRNA mimics or miRNA expression vectors carrying
either a pre-miRNA sequence or an artiﬁcial miRNA hairpin
sequence have been successfully applied to restore or overexpress
miRNA in vitro. Chemically modiﬁed antisense oligonucleotides
are widely used to knock down miRNA. In terms of the
oncogenic function of a subset of miRNAs, such as miR-21
in breast cancer12, decreasing the expression level or blocking the
function of these miRNAs is believed to be a promising strategy
for cancer treatment. Currently, chemically modiﬁed miRNA
inhibitors are frequently applied. The modiﬁcation includes
addition of 20 -O-methyl, 20 -O-methoxyethyl, locked nucleic acid
(LNA) with 20 -O connecting to 40 -C and so on. Although the
modiﬁed nucleic acid structure has high afﬁnity to bind with
a target miRNA, the loss-of-function studies of miRNAs still
need to be scrutinized, to improve the binding speciﬁcity and
exclude the frequent off-target effects. In addition, two other
approaches were reported to block miRNA function. One is called
miRNA-sponge13, which serves as a competitive inhibitor
of miRNAs. An expression vector carrying multiple binding
sites to an miRNA is introduced into cells. Following the vector
gene transcription, the overexpressed synthetic binding sequences
occupy the endogenous miRNA in the cells with high-afﬁnity
blocking miRNA regulation of its target genes. The other
approach is called miRNA mask14, which uses oligonucleotides
perfectly complementary to miRNA-binding sites of target
mRNAs. The miRNA mask blocks the access of a miRNA to
the binding sequence of target mRNAs, thereby blocking the
miRNA–mRNA interaction. However, the approaches for
miRNA loss of function using either miRNA sponge or miRNA
mask are not widely accepted due to the limited effect and
complicated regulatory mechanisms in vivo.
Breast cancer is the most common cancer in women. Although
the 5-year survival has reached around 98% in localized breast
cancer15, metastatic breast cancer, which occurs in 20–30% of
breast cancer patients, remains incurable due to the lack of a
reliable target for treatment16. miRNAs regulate breast cancer
initiation and progression3,9. Altered expression of miRNAs or
mutation of miRNA genes have been described in human breast
cancer9,17. Zhang et al.18 analysed 283 human miRNA genes in
55 human breast primary tumours and 18 human breast cancer
cell lines, demonstrating a high frequency (B72.8%) of gene copy
number abnormality in miRNA-containing regions in human
breast cancer. A growing body of evidence implicates miRNAs in
regulating breast cancer metastasis and epithelial to mesenchymal
transition19,20.
Herein, DNA oligos are specially designed to bind to the 50 -half
sequence of one molecule and the 30 -half sequence of another
2

molecule of the target miRNA through a complementary
interaction, which we term a ‘small RNA zipper’. As the small
RNA zippers are chemically modiﬁed as LNAs, the binding to
target miRNA has high afﬁnity, high speciﬁcity and high stability.
The small RNA zipper is able to connect the target miRNA
molecules end to end forming a stable structure, blocking the
functions of the miRNA. Two miRNAs, miR-221 and miR-17,
has been validated in human breast cancer cell lines demonstrating B70–90% knockdown of miRNA levels by corresponding
small RNA zippers at 24 h after transfection. The miR-221 zipper
can rescue the expression of p27, a target gene of miR-221, and
reverse the cell-migration-promoting function of miR-221 in
breast cancer cells. In addition, by application of the miR-221
zipper, we demonstrate that miR-221 may confer doxorubicin
(Dox) resistance in human breast cancer cells.
Results
Construction of small RNA zippers. In view of the small size
of miRNAs, an oligonucleotide was specially designed to be
complementary to the second half sequence of a miRNA molecule
and the ﬁrst half of another, thereafter connecting miRNA
molecules end to end as shown in Fig. 1a. It is named a small
RNA zipper, in which a nucleotide gap was designed between
two miRNA molecules to provide space for a stable structure
formation to ensure binding speciﬁcity to its target sequence.
As such, for a given miRNA, all individual molecules can be
connected end to end via the small RNA zipper following the
zipper strategy (Fig. 1b). To avoid self-complementarity and
to enhance binding speciﬁcity, LNA nucleosides were applied to
synthesize the small RNA zipper. LNA is a class of nucleic acid
analogues in which the ribose ring is ‘locked’ by a methylene
bridge connecting the 20 -O atom and the 40 -C atom.
Effect of small RNA zippers on target miRNA levels.
To determine the effect of the small RNA zipper on the target
miRNA level, miR-17 zipper was synthesized (Fig. 2a)
and transfected into breast cancer cell lines MCF-7 and
MDA-MB-231. The abundance of miR-17 in the cells was
analysed and compared using quantitative real-time PCR before
and after transfection of the miR-17 zipper. miR-17 abundance
was knocked down around 70–90% by miR-17 zipper at 24
and 48 h after transfection, which was conﬁrmed by quantitative
real-time PCR using both the SYBR approach (Fig. 2b,c) and
the Taqman approach (Supplementary Fig. 1A). In comparison,
a negative control zipper did not show an effect on the miR-17
abundance (Supplementary Fig. 1B).
In addition to miR-17, miR-221, which has been reported
to promote cellular migration and invasion in breast cancer4,
was tested by small RNA zipper (Fig. 2d–g). miR-221 has
high expression in the MDA-MB-231 breast cancer cell line but
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Figure 1 | The construction of small RNA zipper. (a) Schematic
representation of the interaction between small RNA zipper and small
RNAs. (b) Schematic representation of how the small RNA zippers connect
the target small RNA molecules end to end, forming an RNA–DNA duplex.
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Figure 2 | The effect of small RNA zippers on the target miRNA levels. (a) Construction of miR-17 zipper. (b,c) Quantitative real-time PCR analysis
showing the decreased level of miR-17 in MDA-MB-231 cells after transfection of miR-17 zipper. Data are mean ±s.e.m. **Po0.01 (miR zipper groups
versus control groups or 0 h before transfection, t-test, n ¼ 3). (d) Construction of miR-221 zipper. (e,f) Quantitative real-time PCR analysis showing the
decreased level of miR-221 in MDA-MB-231 cells after transfection of miR-221 zipper. Data are mean ±s.e.m. *Po0.05 and **Po0.01 (miR zipper groups
versus control groups or 0 h before transfection, t-test, n ¼ 3). (g,h) Quantitative real-time PCR analysis showing the dose response of the miR-221 levels to
the concentration of the miR-221 zipper (g) and negative control (h), demonstrating the highest efﬁciency under the condition of 50 nM concentration and
24 h transfection. Data are mean ±s.e.m. **Po0.01 (different concentrations of miR zipper groups versus 0 nM blank control, t-test, n ¼ 3).

low expression in MCF-7 cells; therefore, MDA-MB-231
cells were used to test the effect of the miR-221 zipper. Similar
to the miR-17 zipper, the miR-221 zipper decreased the amount
of miR-221 at 24 and 48 h after transfection compared with
a negative control (Fig. 2e,f and Supplementary Fig. 2A). A dose
response assay indicated the knockdown efﬁciency of miR-221
was positively correlated with the concentration of the miR-221
zipper (Fig. 2g and Supplementary Fig. 2). The control zipper

did not affect the expression of miR-221 up to a high
concentration of 50 nM (Fig. 2h). miR-221 expression was
knocked down B90% by the miR-221 zipper at the
concentration of 50 nM in MDA-MB-231 cells, which showed
much higher efﬁciency than the lower concentrations. In contrast,
miR-222, another member of the miR-221/222 cluster but
with a different sequence to miR-221 (Supplementary Fig. 3A),
did not show a knockdown effect by the miR-221 zipper
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(Supplementary Fig. 3B), indicating the sequence speciﬁcity
of small RNA zipper binding to target miRNAs. In addition,
a head-to-head comparison between miR-221 zipper and
anti-miR-221 indicated that both approaches can knockdown
miR-221 around 70–90%, depending on the concentration and
transfection efﬁciency (Supplementary Fig. 4).
Optimization of small RNA zipper construction. As shown
in Fig. 1, small RNA zipper technology was developed to connect
the target small RNA one by one. In consideration of the
RNA–DNA duplex formation and sequence-speciﬁc binding,
one additional nucleotide was designed in the zipper sequence,
to introduce a nucleotide gap between two target small RNAs.
To demonstrate whether the gap is required, a LNA oligonucleotide without a gap between two target RNA molecules, named
small RNA Dzipper, was designed for comparison. Following
this strategy, the LNA miR-221 Dzipper and the miR-17 Dzipper
were synthesized as shown in Fig. 3. The efﬁciency of miR-221
knockdown was compared between the same concentrations
of miR-221 zipper and Dzipper (Fig. 3a–d). Both miR-221
zipper and Dzipper decreased the abundance of miR-221 in
MDA-MB-231 cells, whereas miR-221 zipper showed a higher
efﬁciency than miR-221 Dzipper (Fig. 3b–d).
The comparison between the miR-17 zipper and Dzipper
(Fig. 3e) was performed in MCF-7 cells. The abundance of
miR-17 was analysed using northern blot hybridization (Fig. 3f).
The effect of the miR-17 zipper on miR-17 abundance was dose
dependent. miR-17 zipper knocked down the miR-17 level at
the concentrations of 20 and 30 nM, whereas miR-17 Dzipper

a

5′

3′

was not as effective as miR-17 zipper at the concentration
of 20 nM, indicating the higher efﬁciency of the miR-17 zipper
than miR-17 Dzipper to reduce the miR-17 level.
Sequence speciﬁcity of small RNA zipper. To validate
the sequence speciﬁcity of binding between a small RNA zipper
and target miRNA, miR-222 was tested in MDA-MB-231
cells transfected with miR-221 zipper. miR-221 and miR-222,
two members of a miRNA cluster, which is located on chromosome X, share the same ‘seed’ sequence but the rest of the
sequence is different (Supplementary Fig. 3A). As described
above, knockdown of miR-221 abundance showed a
dose response to the miR-221 zipper (Fig. 2g). However, miR-222
did not show a response to either low or high concentrations
of miR-221 zipper (Supplementary Fig. 3B). This was further
conﬁrmed when the miR-221 zipper and Dzipper were applied, to
determine the effect on the abundance of miR-221 and miR-222
(Fig. 3c,d).
Let-7 was tested to further validate the speciﬁcity of the
miRNA zipper because of the strong homology between let-7
family members. The family members including let-7a, let-7b and
let-7c have moderate expression in MDA-MB-231 cells
(Supplementary Fig. 5). Let-7a zipper (Fig. 4a) was transfected
to MDA-MB-231 cells followed by a quantitative analysis of
let-7a, let-7b and let-7c in 24 h. It was clearly shown there
was signiﬁcant knockdown of let-7a, but not let-7b nor let -7c, by
the let-7a zipper (Fig. 4b).
Point mutations including a two nucleotides mutation (miR-17
zipper mu1) and a single-nucleotide mutation (miR-17 zipper mu2)
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were applied to miR-17 zipper as shown in Fig. 4c. Consistently,
miR-17 expression in MDA-MB-231 cells was knocked down
70B90% at 24 and 48 h after transfection with miR-17 zipper,
but not with mutated miR-17 zippers (Fig. 4d). Notably, miR-17
zipper mu2 showed a small effect on the miR-17 expression,
although the P-value did not support a signiﬁcant change (Fig. 4d).
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pairing, further demonstrating the sequence speciﬁcity of a miRNA
zipper interacting with target miRNA.
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Emerging evidence indicates that many miRNAs have iso-miRs
differing by B1–3 nucleotides at either the 50 - or 30 -end of
the miRNA molecules. To determine the effect of miRNA zippers
on iso-miRs, quantitative analysis of miR-17, iso-miR-17-1
(one additional nucleotide at the 30 -end) and iso-miR-17-2
(two additional nucleotides at the 30 -end; Fig. 4e) were performed
in MDA-MB-231 cells following miR-17 zipper treatment
(Fig. 4f). Both iso-miR-17-1 and iso-miR-17-2 themselves have
lower expression than miR-17 in cells (Supplementary Fig. 6A).
Our analysis indicated that the effect of the miR-17 zipper was
not limited to miR-17, but also to the expression of two iso-miRs
(Fig. 4e,f). Similarly, the miR-221 zipper was demonstrated to be
able to knockdown both miR-221 and iso-miR-221 in cells
(Fig. 4g,h). As the complementary binding between the miRNA
zipper and iso-miRs is totally the same as that between the
miRNA zipper and miRNA, the interaction between the miRNA
zipper and iso-miRs may follow the structure as shown in
Supplementary Fig. 6B. In consideration of isomiRs with three or
more extra nucleotides, which have not been tested yet by the
miRNA zippers, isomiR-sequence-speciﬁc zipper is strongly
suggested rather than miR zipper, to knock down isomiRs.
Functional validation of small RNA zipper. To determine
whether the small RNA zippers are safe and functional in cells,
different concentrations (0, 10, 30 and 50 nM) of miR-221 zippers
were introduced into MDA-MB-231 cells. After 24 h, Annexin
V staining was performed to quantify the dead and apoptotic cells
(Fig. 4i). Quantitative analysis indicated B5% of total dead and
apoptotic cells in all tests. No signiﬁcant difference was found
between control and miR-221 zipper-treated cells (Fig. 4j),
indicting the non-toxicity of small RNA zipper to cells. H2O2 was
used as a positive control to induce cell apoptosis (Supplementary
Fig. 7).
Anti-miRNA has been shown to knock down target miRNA
and thereby block its biological function. miRNA zippers have
similar effects on the target miRNA levels. The cellular
phenotypes of the miR-221 zipper and anti-miR-221 in
MDA-MB-231 cells were compared. It has been well demonstrated that miR-221 promotes cell migration and invasion in
MDA-MB-231 cells4, which was attenuated by transfection
of anti-miR-221 as shown in Fig. 5a,b. Similarly, transfection of
miR-221 zipper into MDA-MB-231 cells suppressed the cellular
migration (Fig. 5c). The migration of living cells was recorded for
48 h (Supplementary Movie 1 and 2, and Fig. 5c) and quantitatively analysed (Fig. 5d). At the same time, the effect on the
cellular migration of miR-221 Dzipper was tested and compared
with miR-221 zipper. miR-221 Dzipper showed an inhibitory
function that was less than miR-221 zipper (Fig. 5c,d and
Supplementary Movie 3).

miR-221 has been reported to promote tamoxifen resistance
in ERa-positive breast cancer cells21,22. We tested whether
miR-221 has any correlation with Dox resistance in breast
cancer cells. Surprisingly, miR-221 expression showed a B5-fold
increase in the Dox-resistant breast cancer cell lines including
MCF-7 (Fig. 5e) and MDA-MB-231 (Fig. 5f). Introduction of
anti-miR-221 into MDA-MB-231 cells increased the sensitivity to
Dox (Fig. 5g). Similarly, transfection of the miR-221 zipper into
MDA-MB-231 cells attenuated Dox resistance as shown in
Fig. 5h. Notably, the miR-221 zipper was more effective than antimiR-221, to increase cellular sensitivity to 200 nM Dox
(Fig. 5g,h).
Effect of small RNA zipper on target genes of miRNA. To
determine the effects of the miRNA zipper on the expression of
miRNA target genes, the interaction between miR-221 and
p27 was assessed on application of the miR-221 zipper.
p27 mRNA carries two binding sites for miR-221/222 in the
30 -UTR (Fig. 6a). p27 has been well conﬁrmed to be a target gene
of miR-221/222 in breast cancer. Consistent with the knockdown
of miR-221, p27 expression was upregulated by the miR-221
zipper in MDA-MB-231 cells (Fig. 6b,c). The luciferase reporter
constructs carrying either wild-type (WT) p27 30 -UTR or point
mutated p27 30 -UTR (mutations in the two binding sites of
miR-221/222) were tested to interact with miR-221/222 in
MDA-MB-231 cells (Fig. 6d). As expected, increased luciferase
activity was observed with miR-221 zipper applied to WT p27
30 -UTR (Fig. 6e). Owing to the unaffected expression of miR-222
in the miR-221 zipper-treated cells, the increased level of
luciferase activity by miR-221 zipper was not as high as that by
mutated p27 30 -UTR. (Fig. 6e).
Discussion
Since the ﬁrst discovery of miRNA in 1993 (ref. 23) and
the conﬁrmation of miRNA function in 2001 (refs 24–26),
thousands of miRNAs have been identiﬁed from eukaryotes. The
aberrant expression of miRNA has been frequently reported
in various diseases including cancer9. However, the function of
most miRNAs remains to be discovered and few miRNA–target
interactions have been experimentally validated in vitro or in vivo.
To identify the function of miRNA and determine the
relationship of miRNAs to diseases, different approaches have
been applied to result in a loss or gain of miRNA function
accompanied with increased or decreased levels of endogenous
target genes. Presently, loss-of-function phenotypes are induced
by means of chemically modiﬁed antisense oligonucleotides
including 20 O-methyl, LNA, phosphorothioate, cholesterol and
so on, which work by annealing to mature miRNAs to block
miRNA from binding to target genes. Herein, a small RNA zipper

Figure 4 | Speciﬁcity of miRNA zipper to knock down target miRNA. (a) Sequence and construction of miRNA let-7a zipper. (b) Quantitative analysis of
let-7a, let-7b and let-7c in MDA-MB-231 cells at 24 h after transfection with 30 nM let-7a zipper. Data are mean ±s.e.m. *Po0.05, (zipper group versus
control group, t-test, n ¼ 3). (c) Sequences of miR-17-zipper and point mutated miR-17 zippers (miR-17-zipper mu1 and mu2). The mutated nucleotides
were indicated with red font. (d) Quantitative analysis of the miR-17 levels in MDA-MB-231 cells at 24 h after transfection with 30 nM of control,
mR-17-zipper and mutated miR-17-zippers, respectively. Data are mean ±s.e.m. *Po0.05 (zipper groups versus control group, t-test, n ¼ 3).
(e) Sequences of mature miR-17 and two miR-17 iso-miRs which have one to two additional nucleotides at the 30 -end of miR-17. (f) Quantitative analysis of
miR-17 and iso-miRs in MDA-MB-231 cells at 24 h after transfection with 30 nM of mR-17-zipper. The results indicated the knockdown effects of both
miR-17 and iso-miRs by miR-17 zipper. Data are mean ±s.e.m. **Po0.01 (zipper groups versus control groups, t-test, n ¼ 3). (g) Sequences of mature
miR-221 and miR-221 iso-miRs which have 1-2 additional nts at the 30 end of miR-221. (h) Quantitative analysis of miR-221 and iso-miRs in MDA-MB-231
cells at 24 h after transfection with 30 nM of mR-221-zipper. The results indicated the knockdown effects of both miR-221 and iso-miR-221 by miR-221
zipper. Data are mean ±s.e.m. **Po0.01 (zipper groups versus control groups, t-test, n ¼ 3). (i) Annexin V staining for dead and apoptotic MDA-MB-231
cells at 24 h after transfection with 0, 10, 30 and 50 nM of miR-221 zipper, respectively. (j) Quantitative analysis of I indicated B5% of total dead and
apoptotic cells in all groups. No signiﬁcant difference for dead and apoptotic cell percentage was found between cells treated with different concentrations
of miR-221 zipper (t-test, n ¼ 3).
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Figure 5 | Functional validation of miR-221 zipper in human breast cancer cells. (a) Anti-miR-221 suppressed cellular migration in MDA-MB-231 cells.
Scale bar, 50 mm. (b): Quantitative analysis of A. Data are mean ±s.e.m. *Po0.05 (anti-miR-221 groups versus control groups, t-test, n ¼ 3).
(c) The effects of miR-221 zipper and miR-221 Dzipper on cellular migration after transfection into MDA-MB-231 cells. The migration of living cells was
recorded continuously for 48 h. Scale bar, 50 mm. (d) Quantitative analysis of C. Data are mean ±s.e.m. *Po0.05 (zipper groups versus control groups,
t-test, n ¼ 3). (e) Increased miR-221 expression in Dox-resistant MCF-7 cells. Data are mean ±s.e.m. *Po0.05 (Dox. group versus control group, t-test,
n ¼ 3). (f) Increased miR-221 expression in Dox-resistant MDA-MB-231 cells. Data are mean ±s.e.m. *Po0.05 (Dox. group versus control group, t-test,
n ¼ 3). (g) anti-miR-221 promoted the sensitivity of MDA-MB-231 cells to 200 nM Dox. Data are mean ±s.e.m. *Po0.05 (anti-miR-221 group versus
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was speciﬁcally designed and successfully applied to connect
miRNA molecules end by end, forming a DNA–RNA duplex
through a complementary interaction with high afﬁnity,
high speciﬁcity and high stability. Two miRNAs, miR-221 and
miR-17, were tested in human breast cancer cell lines,
demonstrating a dose-dependent knockdown efﬁciency of

miR-221 and miR-17 by the miR-221 zipper and miR-17
zipper, respectively. With up to 50 nM concentrations of
the miRNA zippers, the expression level of target miRNA
can be suppressed around 70B90%. The speciﬁcity of miRNA
zippers was conﬁrmed by testing homologous miRNA
family members and miRNA zipper point mutations. A head to
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Figure 6 | Effect of miR-221 zipper to the target gene of miR-221. (a) Sequence alignment showing the 30 -UTR of human p27 mRNA has two binding sites
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protein loading control. See also Supplementary Fig.9. (c) Western blot analysis showing increased p27 expression in MDA-MB-231 cells by miR-221 zipper
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head comparison between the miRNA zipper and antisense
inhibitor indicated similar efﬁciency to knock down the target
miRNA expression.
The miRNA zippers were conﬁrmed to be non-toxic to
cells. Transfection with 50 nM miRNA zipper to a human breast
cancer cell line led to B90% knockdown of most of the target
miRNAs without inducing cell apoptosis. Furthermore,
the miRNA zipper is functional in cells to reverse the cellular
phenotypes caused by a given miRNA. For example, the miR-221
zipper rescued the suppression of the target gene p27 by miR-221.
The oncogenic function of miR-221, including promoting
cellular migration and invasion in breast cancer cells, was
reversed by the miR-221 zipper.
Taken together, these ﬁndings show the small RNA zipper is a
type of inhibitor for small RNAs including miRNAs, which
can induce miRNA loss-of-function phenotype. This may provide
an approach to determine the function of a miRNA and also
to conﬁrm the target genes of miRNAs.
8

In view of the similar characteristics, including small size
and single strand, shared by miRNAs, small interfering RNAs
(siRNAs) and piwi-interacting RNAs (piRNAs), small
RNA zipper technology should be applicable to induce loss-offunction of not only miRNAs but also endogenous siRNAs
and piRNAs. That is why we have used term the small RNA
zipper rather than miRNA zipper. However, it will clearly
be necessary to experimentally validate the effect and function of
small RNA zippers on other types of small RNAs including
siRNAs and piRNAs.
To obtain a stable DNA–RNA duplex, LNA-enhanced
oligonucleotides are applied to small RNA zippers, in which
the LNA nucleic acid analogue is ‘locked’ by a methylene
bridge connecting the 20 -O atom and the 40 -C atom. LNA can
bind very tightly to complementary residues with high binding
speciﬁcity, whereas avoiding unacceptable secondary structure
and self-complementarity27. In addition, we have demonstrated
that LNA G–T may not have wobble interaction as G–U by

NATURE COMMUNICATIONS | 8:13964 | DOI: 10.1038/ncomms13964 | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13964

producing a G–U wobble base pairing between the miRNA
zippers and miRNAs.
By application of the miR-221 zipper in human breast cancer
cells, a function of miR-221 was conﬁrmed that high expression
of miR-221 may be responsible at least in part for the
Dox-resistance in breast cancer cells. miR-221 has been well
demonstrated to promote cellular migration and invasion in
breast cancer4. miR-221 was reported to promote tamoxifen
resistance in ERa-positive breast cancer cells22. In the current
study we found overexpression of miR-221 in the Dox-resistant
breast cancer cells. Knockdown of miR-221 by miR-221 zipper
increased the sensitivity of MDA-MB-231 cells to Dox. These
observations indicate miR-221 may be a promising therapeutic
target to prevent chemo resistance in breast cancer and prevent
cancer cell metastasis.
Methods
Cell lines and cell culture. Human breast cancer cell lines MDA-MB-231 and
MCF-7 were originally purchased from ATCC (Manassas, VA) and maintained
in our laboratory. DMEM medium containing penicillin and streptomycin
(100 mg l  1) and 10% fetal bovine serum (FBS) at 37 °C in a humidiﬁed environment with 5% CO2 was applied for cell culturing.
Oligos and transfection. LNA miRNA zipper and miRNA Dzipper were designed
following LNA Oligo Tools and Design Guidelines of Exiqon (Vedbaek, Denmark),
and synthesized by Exiqon and GenScript (Nanjing, China). The oligo sequences
are (from 50 to 30 ): miR-17 zipper 50 -A þ AGCACTTTGGCTACCTGCACT þ GT30 ; miR-17 Dzipper 50 -A þ AGCACTTTGCTACCTGCACT þ GT; miR-221
zipper 50 -AA þ TGTAGCTAGAAACCCAGCA þ GAC-30 ; miR-221 Dzipper
50 -AA þ TGTAGCTGAAACCCAGCA þ GAC-30 ; let-7a zipper 50 -CTACTA
CCTCACAACT þ ATACA þ AC-30 ; miR-17 zipper mu1 50 -A þ AGCACTATG
GCTACCTGGACT þ GT-30 ; and miR-17 zipper mu2 50 -A þ AGCACTTT
GGCTACCTGCGCT þ GT-30 . Negative control was a commercially available
LNA product from Exiqon. Anti-miR-221 and control were purchased from
Ambion of Life Technologies. The HiPerFect transfection reagent from Qiagen
was used for cell transfection following the manufacturer’s instructions. Final
concentration for miRNA zipper and anti-miRNA was 30 nM, except for
dose–response assays.
miRNA real-time PCR analysis. Total RNA was extracted with Trizol reagent
(Invitrogen). First-strand complementary DNA of miRNAs was prepared using the
M&G miRNA Reverse Transcription kit (miRGenes, Shanghai, China) following
the manufacturer’s instruction. Forward primer sequences for real-time PCR of
miRNAs were: miR-16, 50 -agcagcacgtaaatattggc-30 ; miR-221, 50 -agctacattgtctgct-30 ;
miR-222, 50 -agctacatctggctact-30 ; let-7a, 50 -tgaggtagtaggttgtata-30 ; let-7b, 50 -tgaggtagtaggttgtgtg-30 ; let-7c, 50 -tgaggtagtaggttgtatg-30 ; iso-miR-17-1, 50 -tgcttacagtg
caggtagt-30 ; iso-miR-17-2, 50 -tgcttacagtgcaggtagtg-30 ; iso-miR-221-1, 50 -ctacattgt
ctgctgggtttca-30 ; iso-miR-221-2, 50 -ctacattgtctgctgggtttcag-30 ; and 5s ribosomal
RNA, 50 -agtacttggatgggagaccg-30 . All the primer oligoes were synthesized and
puriﬁed by GenScript. The Taqman probe was from Ambion. The SYBR Green
Master Mix was ABI product (Applied Biosystem, Life Technologies). The ABI
7900 HT Sequence Detection System (Applied Biosystem, Life Technologies) was
used for quantitative real time PCR assay. miR-16 and 5s rRNA were used for
normalization in the SYBR approach. U6 was used for normalization in the
Taqman approach
Northern blot analysis. Northern blot analysis of miRNAs was performed as
described before28. Brieﬂy, total RNA (10–20 mg per lane) was loaded on a
15% denaturing polyacrylamide gel and electophoresed at 200 V until the
bromophenol blue approached the bottom. The RNA was transferred from the
gel to Hybond-N þ membrane using a Semi-Dry Transfer Apparatus. DNA
oligonucleotide probes were 50 -end labelled with [g-32P]-ATP and hybridization
was carried out using Rapid-Hyb buffer following the manufacturer’s instructions
(Amersham, Piscataway, NJ). Uncropped versions of all blots are available in
Supplementary Figs 8 and 9.
Western blot analysis. Cell lysates (50 mg) were prepared after 24 and/or 48 h
transfection of miRNA zipper or anti-miRNA and separated by 10% SDS–PAGE.
The proteins were transferred to nitrocellulose membrane. After being blocked in
5% milk (w/v) at room temperature for 1 h, the membranes were incubated at
4 °C overnight with primary antibodies (1:2,000). Following 1  PBST washing,
the membranes were incubated with secondary antibodies (1:3,000) at room
temperature for 1 h followed by staining. The following antibodies were used
for western blotting: anti-p27 (sc-776) and anti-b-actin (sc-47778; purchased from

Santa Cruz Biotechnology). Uncropped versions of all blots are available in
Supplementary Figs 8 and 9.
Wound-healing assay. Cells were counted and plated in equal numbers in 12-well
tissue culture plates to achieve 95% conﬂuence. Thereafter, a vertical wound was
created using a 0.1 ml pipette tip. The cells were cultured with FBS-reduced DMEM
medium (0.1% FBS). Images of the wound were captured at designated times to
assess wound closure rate.
Video recording of living cell migration. MDA-MB-231 cells were seeded in a
six-well plate, and growing until forming conﬂuent monolayer. A B300 mm-wide
linear wound was made using a sterile 10 ml pipette tip. The suspend cells were
washed away with PBS buffer. The remaining cells were cultured in DMEM
medium containing 0.1% FBS. Cells were allowed to close the wound for 48 h
and the wound areas were photographed with the Live Cell Imaging System
(Leica DMI600B) every 15 min.
Statistical analysis. All data are presented as mean±s.e.m. unless stated otherwise. The two-tailed Student’s t-test (unpaired) was used to compare difference
between groups, in which Po0.05 was considered statistically signiﬁcant.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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